Clinical Trial

Peripheral Arterial Disease Biomarkers

Study acronym: PADBIRD
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 18, 2024 (before its estimated December 31, 2024 completion). Its status may not reflect the trial's current state.
Summary
The study aims to determine how expression levels of biomarkers for peripheral arterial disease change over time in response to exercise therapy, surgical or endovascular intervention, and whether they can be used to predict disease progression.
Trial Details
NCT Number NCT06373302
Lead Sponsor Norfolk and Norwich University Hospitals NHS Foundation Trust
Conditions Peripheral Arterial Disease
Enrollment 100 participants
Start Date 2024-05-01
Primary Completion 2024-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-04-18